Publication | Closed Access

Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914/SEN34625

Neuropsychological FunctioningPsychiatryPsychotic DisorderMedicineDementiaCognitive DysfunctionPsychopharmacologySchizophreniaNeuropharmacologyNeuropsychiatrySocial SciencesNeurosciencePreclinical AssessmentAdjunctive Treatment ApproachPsychopathology